ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019

San Diego Biotechnology Network
San Diego Biotechnology Network
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019
Loading
/

SAN DIEGO–(BUSINESS WIRE)–ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended June 30, 2019. Fourth Quarter 2019 Highlights Revenue increased 13% to $705.0 million; up 15% on a constant currency basis Gross margin expanded 120 bps to 59.3% Net operating profit decreased 18%; non-GAAP operating profit up 18% GAAP diluted earnings per share of $0.48; non-GAAP diluted earnings per share of $0.95 Quarterly dividend increased b